{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:30:49Z","timestamp":1780471849611,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,5,31]],"date-time":"2014-05-31T00:00:00Z","timestamp":1401494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10067-014-2675-2","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T22:57:13Z","timestamp":1401404233000},"page":"1113-1118","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis"],"prefix":"10.1007","volume":"33","author":[{"given":"Abdolreza","family":"Malek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Reza","family":"Raeeskarami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ziaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Aghighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad-Hassan","family":"Moradinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,31]]},"reference":[{"key":"2675_CR1","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldman","year":"2008","unstructured":"Feldman BM, Rider LG, Reed AM et al (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201\u20132212","journal-title":"Lancet"},{"key":"2675_CR2","first-page":"375","volume-title":"Textbook of pediatric rheumatology","author":"JT Cassidy","year":"2010","unstructured":"Cassidy JT, Lindsley CB (2010) Juvenile dermatomyositis. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 6th edn. Elsevier Saunder, Philadelphia, pp 375\u2013413","edition":"6"},{"key":"2675_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C et al (2010) Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res 62:63\u201372","journal-title":"Arthritis Care Res"},{"key":"2675_CR4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"2675_CR5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"issue":"1","key":"2675_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1546-0096-10-34","volume":"10","author":"A Patwardhan","year":"2012","unstructured":"Patwardhan A, Rennebohm R, Rennebohm R, Dvorchik I, Spencer CH (2012) Is juvenile dermatomyositis a different disease in children up to three years of age at onset than in children above three years at onset? A retrospective review of 23\u00a0years of single center experience. Pediatr Rheumatol 10(1):34","journal-title":"Pediatr Rheumatol"},{"key":"2675_CR7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/art.23341","volume":"59","author":"KA Rouster-Stevens","year":"2008","unstructured":"Rouster-Stevens KA, Gursahaney A, Ngai KL et al (2008) Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum 59:222\u2013226","journal-title":"Arthritis Rheum"},{"key":"2675_CR8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0889-857X(02)00024-8","volume":"28","author":"AV Ramanan","year":"2002","unstructured":"Ramanan AV, Feldman BM (2002) Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin N Am 28:833\u2013857","journal-title":"Rheum Dis Clin N Am"},{"key":"2675_CR9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00002281-200211000-00005","volume":"14","author":"AV Ramanan","year":"2002","unstructured":"Ramanan AV, Feldman BM (2002) Clinical outcomes in juvenile dermatomyositis. Curr Opin Rheumatol 14:658\u2013662","journal-title":"Curr Opin Rheumatol"},{"key":"2675_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","volume":"84","author":"AM Sallum","year":"2008","unstructured":"Sallum AM, Pivato FC, Doria-Filho U et al (2008) Risk factors associated with calcinosis of juvenile dermatomyositis. J Pediatr 84:68\u201374","journal-title":"J Pediatr"},{"key":"2675_CR11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaad.2006.05.005","volume":"55","author":"E Pope","year":"2006","unstructured":"Pope E, Janson A, Khambalia A et al (2006) Childhood acquired lipodystrophy: a retrospective study. J Am Acad Dermatol 55:947\u2013950","journal-title":"J Am Acad Dermatol"},{"key":"2675_CR12","first-page":"610","volume":"28","author":"C Huemer","year":"2001","unstructured":"Huemer C, Kitson H, Malleson PN et al (2001) Lipodystrophy in patients with juvenile dermatomyositis\u2014evaluation of clinical and metabolic abnormalities. J Rheumatol 28:610\u2013615","journal-title":"J Rheumatol"},{"key":"2675_CR13","first-page":"50","volume":"23","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, Constantin T, Balogh Z, Szalai Z, Borgulya G, Moln\u00e1r K, Tefner I, Garami M, Fekete G, Dank\u00f3 K (2005) Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis. Clin Exp Rheumatol 23:50\u201356","journal-title":"Clin Exp Rheumatol"},{"key":"2675_CR14","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","volume":"45","author":"LJ McCann","year":"2006","unstructured":"McCann LJ, Juggins AD, Maillard SM et al (2006) The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)\u2014clinical characteristics of children recruited within the first 5\u00a0yr. Rheumatology 45:1255\u20131260","journal-title":"Rheumatology"},{"key":"2675_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP, Lipton R, Ramsey-Goldman R et al (2003) US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300\u2013305","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2675_CR16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/s10165-012-0647-4","volume":"23","author":"T Kishi","year":"2013","unstructured":"Kishi T, Miyamae T, Hara R et al (2013) Clinical analysis of 50 children with juvenile dermatomyositis. Mod Rheumatol 23(2):311\u2013317","journal-title":"Mod Rheumatol"},{"key":"2675_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1529-0131(200003)43:3<541::AID-ANR9>3.0.CO;2-T","volume":"43","author":"AM Huber","year":"2000","unstructured":"Huber AM, Lang B, LeBlanc CM et al (2000) Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43:541\u2013549","journal-title":"Arthritis Rheum"},{"key":"2675_CR18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jpeds.2009.09.008","volume":"156","author":"DM Levy","year":"2010","unstructured":"Levy DM, Bingham A, Kahn PJ, Eichenfield AH, Imundo LF (2010) Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids. J Pediatr 156:302\u2013307","journal-title":"J Pediatr"},{"issue":"3","key":"2675_CR19","first-page":"271","volume":"17","author":"A Hashemzadeh","year":"2007","unstructured":"Hashemzadeh A, Heydarian F (2007) Juvenile dermatomyositis; clinical and laboratory assays. Iran J Pediatr 17(3):271\u2013274","journal-title":"Iran J Pediatr"},{"key":"2675_CR20","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1002\/art.23899","volume":"58","author":"TP O\u2019Hanlon","year":"2008","unstructured":"O\u2019Hanlon TP, Rider LG, Schiffenbauer A et al (2008) Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis Rheum 58:3239\u20133246","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2675_CR21","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer E, Singh-Grewal D, Feldman BM (2008) Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum 58(11):3585\u20133592","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2675_CR22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5455\/apr.120120111140","volume":"1","author":"R Shiari","year":"2012","unstructured":"Shiari R, Kiumarsi A, Eshgh FA, Allameh MM (2012) Juvenile dermatomyositis in Iranian children; a case series report. Ann Pediatr Rheum 1(1):58\u201364","journal-title":"Ann Pediatr Rheum"},{"issue":"7","key":"2675_CR23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","volume":"59","author":"R Seshadri","year":"2008","unstructured":"Seshadri R, Feldman BM, Ilowite N, Cawkwell G, Pachman LM (2008) The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis. Arthritis Rheum 59(7):989\u2013995","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2675_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1067\/mjd.2002.122196","volume":"47","author":"RE Fisler","year":"2002","unstructured":"Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP (2002) Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47(4):505\u2013511","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"2675_CR25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1529-0131(200012)13:6<360::AID-ART5>3.0.CO;2-Q","volume":"13","author":"MS Klein-Gitelman","year":"2000","unstructured":"Klein-Gitelman MS, Waters T, Pachman LM (2000) The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis. Arthritis Care Res 13(6):360\u2013368","journal-title":"Arthritis Care Res"},{"issue":"6","key":"2675_CR26","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/art.24571","volume":"60","author":"S Kim","year":"2009","unstructured":"Kim S, Moussa D, Fatma D, Zurakowski D, Fuhlbrigge RC, Sundel RP (2009) Complete and sustained drug free remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum 60(6):1825\u20131830","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2675_CR27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3899\/jrheum.090953","volume":"37","author":"E Stringer","year":"2010","unstructured":"Stringer E, Bohnsack J, Bowyer SL, Griffin TA, Huber AM, Lang B et al (2010) Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey. J Rheumatol 37(9):1953\u20131961","journal-title":"J Rheumatol"},{"issue":"1","key":"2675_CR28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1759720X11424460","volume":"4","author":"N Martin","year":"2012","unstructured":"Martin N, Li CK, Wedderburn LR (2012) Juvenile dermatomyositis: new insights and new treatment strategies. Ther Adv Musculoskelet Dis 4(1):41\u201350","journal-title":"Ther Adv Musculoskelet Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2675-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2675-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:57:35Z","timestamp":1559105855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2675-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,31]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2675"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2675-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,31]]}}}